<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">Second malignancy</z:e> is one of the serious late effects among long-term survivors of <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) in children </plain></SENT>
<SENT sid="1" pm="."><plain>Of 83 newly diagnosed <z:e sem="disease" ids="C0023452" disease_type="Neoplastic Process" abbrv="">pediatric ALL</z:e> patients at our hospital between January 1980 and December 1995, four patients were found to have <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>These included <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> after <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, <z:hpo ids='HP_0002859'>rhabdomyosarcoma</z:hpo> after early <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e>, <z:hpo ids='HP_0002888'>ependymoma</z:hpo> after <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, and <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> after early <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The mean duration from initial ALL to <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancy</z:e> was 5.2 years </plain></SENT>
<SENT sid="4" pm="."><plain>The possible causes of <z:e sem="disease" ids="C0085183" disease_type="Neoplastic Process" abbrv="">second malignancy</z:e> in these patients are discussed in this report, along with a review of recent literature </plain></SENT>
</text></document>